Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis | Global Health | JAMA Network Open | JAMA Network
[Skip to Navigation]
Sign In
Figure 1.  Secondary Attack Rates (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Household Contacts and Family Contacts
Secondary Attack Rates (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Household Contacts and Family Contacts

Point sizes are an inverse function of the precision of the estimates, and bars correspond to 95% CIs. CDC indicates Centers for Disease Control and Prevention.

aWeights for the combined estimate are available in eTable 8 in the Supplement.

Figure 2.  Mean Number of Contacts per Household, Secondary Attack Rate (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and Proportion of Households Reporting Any Secondary Transmission From Index Cases
Mean Number of Contacts per Household, Secondary Attack Rate (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and Proportion of Households Reporting Any Secondary Transmission From Index Cases

The expected proportion of households with any secondary transmission (represented by the triangles) was calculated as proportion with at least 1 secondary infection in a household = 1 − (1 −SAR)n, where n is the mean number of contacts for that study (eTable 5 in the Supplement). Point sizes are an inverse function of the precision of the estimates, and bars correspond to 95% CIs.

Figure 3.  Secondary Attack Rates (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Adult (≥18 Years) and Child (<18 Years) Household and Family Contacts
Secondary Attack Rates (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Adult (≥18 Years) and Child (<18 Years) Household and Family Contacts

Point sizes are an inverse function of the precision of the estimates and bars correspond to 95% CIs.

aStudy of family contacts.

Figure 4.  Secondary Attack Rates (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Household and Family Contacts by Relationship to Index Case
Secondary Attack Rates (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Household and Family Contacts by Relationship to Index Case

Point sizes are an inverse function of the precision of the estimates and bars correspond to 95% CIs.

aStudy of family contacts.

Figure 5.  Secondary Attack Rates (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by the Number of People Living in the Same Household as the Index Case
Secondary Attack Rates (SAR) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by the Number of People Living in the Same Household as the Index Case

Point sizes are an inverse function of the precision of the estimates, and bars correspond to 95% CIs.

Supplement.

eFigure 1. PRISMA Flow Diagram for Review of Household Secondary Attack of SARS-CoV-2, MERS-CoV, SARS-CoV, and Other Coronaviruses

eFigure 2. Secondary Attack Rates of SARS-CoV-2 for Studies of Close Contacts

eFigure 3. Funnel Plots of Studies Reporting Secondary Attack Rates of SARS-CoV-2 for Household, Family, and Close Contacts

eFigure 4. Household Secondary Attack Rates of SARS-CoV-2, Restricted to Studies With Low or Moderate Risk of Bias as Determined by the Modified Newcastle-Ottawa Scale

eFigure 5. Household Secondary Attack Rates of SARS-CoV-2, Grouped by Studies in China vs Other Locations

eFigure 6. Secondary Attack Rates of SARS-CoV-2, Grouped by Studies That Tested Only Symptomatic Household Contacts and Studies That Tested All Household Contacts Irrespective of Symptoms

eFigure 7. Household Secondary Attack Rates of SARS-CoV-2, Grouped by Studies Early (January-February) and Later (March-July) in the Pandemic

eFigure 8. Secondary Attack Rates of SARS-CoV-2 From Symptomatic and Asymptomatic or Presymptomatic Index Cases to Household and Family Contacts

eFigure 9. Funnel Plots of Studies Reporting Household Secondary Attack Rates of SARS-CoV-2 for Adult (≥18 Years) and Child (<18 Years) Contacts

eFigure 10. Secondary Attack Rates of SARS-CoV-2 for Household and Family Contacts by Contact Sex

eFigure 11. Funnel Plots of Studies Reporting Household Secondary Attack Rates of SARS-CoV-2 for Female and Male Contacts

eFigure 12. Secondary Attack Rates of SARS-CoV-2 to Household Contacts From Adult (≥18 Years) and Child (<18 Years) Index Cases

eFigure 13. Secondary Attack Rates of SARS-CoV-2 for Household Contacts by Index Case Sex

eFigure 14. Household Secondary Attack Rates of SARS-CoV and MERS-CoV

eTable 1. Electronic Databases and Search Strategy for Household Secondary Attack Rate of SARS-CoV-2, MERS-CoV, SARS-CoV, and Other Coronaviruses

eTable 2. Risk of Bias Assessment for Studies Included in Review of Household Transmissibility of SARS-CoV-2

eTable 3. Description of Index Cases for Studies Included in Review of Household Transmissibility of SARS-CoV-2

eTable 4. Description of Contacts for Studies Included in Review of Household Transmissibility of SARS-CoV-2

eTable 5. Overdispersion of the Number of Secondary Infections of SARS-CoV-2 per Household

eTable 6. Assessment of Factors Potentially Affecting Susceptibility and Infectivity of SARS-CoV-2 in Household Transmission Studies

eTable 7. Household Secondary Attack Rate Comparison With Other Viruses

eTable 8. Weights for Combined Estimate of Secondary Attack Rates of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Household Contacts and Family Contacts

eAppendix 1. Eligibility Criteria

eAppendix 2. Data Extraction

eAppendix 3. Additional Description of Studies

eAppendix 4. Additional Description of Risk Factors

eReferences.

1.
World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions. Published July 9, 2020. Accessed November 11, 2020. https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions
2.
Oran  DP, Topol  EJ.  Prevalence of asymptomatic SARS-CoV-2 infection : a narrative review.   Ann Intern Med. 2020;173(5):362-367. doi:10.7326/M20-3012PubMedGoogle ScholarCrossref
3.
Nishiura  H, Oshitani  H, Kobayashi  T,  et al.  Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19).   medRxiv. Preprint published online April 16, 2020. doi:10.1101/2020.02.28.20029272Google Scholar
4.
World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February 16-24, 2020. Accessed November 11, 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
5.
Badr  HS, Du  H, Marshall  M, Dong  E, Squire  MM, Gardner  LM.  Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study.   Lancet Infect Dis. 2020;20(11):1247-1254. doi:10.1016/S1473-3099(20)30553-3PubMedGoogle ScholarCrossref
6.
Drake  TM, Docherty  AB, Weiser  TG, Yule  S, Sheikh  A, Harrison  EM.  The effects of physical distancing on population mobility during the COVID-19 pandemic in the UK.   Lancet Digit Health. 2020;2(8):e385-e387. doi:10.1016/S2589-7500(20)30134-5PubMedGoogle ScholarCrossref
7.
Fang  H, Wang  L, Yang  Y. Human mobility restrictions and the spread of the novel coronavirus (2019-nCoV) in China. National Bureau of Economic Research. Published March 2020. Accessed November 11, 2020. https://www.nber.org/papers/w26906
8.
Curmei  M, Ilyas  A, Evans  O, Steinhardt  J.  Estimating household transmission of SARS-CoV-2.   medRxiv. Preprint published online June 27, 2020. doi:10.1101/2020.05.23.20111559Google Scholar
9.
US Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): how to protect yourself and others. Updated November 4, 2020. Accessed November 11, 2020. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
10.
Wells  G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Accessed November 11, 2020. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
11.
Fung  HF, Martinez  L, Alarid-Escudero  F,  et al; SC-COSMO Modeling Group.  The household secondary attack rate of SARS-CoV-2: a rapid review.   Clin Infect Dis. Published online October 12, 2020:ciaa1558. doi:10.1093/cid/ciaa1558PubMedGoogle Scholar
12.
Freeman  MF, Tukey  JW.  Transformations related to the angular and the square root.   Annals Math Stat. 1950;21(4):607-611. doi:10.1214/aoms/1177729756Google ScholarCrossref
13.
Higgins  JP, Thompson  SG, Deeks  JJ, Altman  DG.  Measuring inconsistency in meta-analyses.   BMJ. 2003;327(7414):557-560. doi:10.1136/bmj.327.7414.557PubMedGoogle ScholarCrossref
14.
Viechtbauer  W.  Conducting meta-analyses in R with the metafor package.   J Stat Software. 2010;36(3):1-48. doi:10.18637/jss.v036.i03Google ScholarCrossref
15.
R Core Team. R: a language and environment for statistical computing. Accessed November 13, 2020. https://www.gbif.org/tool/81287/r-a-language-and-environment-for-statistical-computing
16.
Begg  CB, Mazumdar  M.  Operating characteristics of a rank correlation test for publication bias.   Biometrics. 1994;50(4):1088-1101. doi:10.2307/2533446PubMedGoogle ScholarCrossref
17.
Egger  M, Davey Smith  G, Schneider  M, Minder  C.  Bias in meta-analysis detected by a simple, graphical test.   BMJ. 1997;315(7109):629-634. doi:10.1136/bmj.315.7109.629PubMedGoogle ScholarCrossref
18.
Duval  S, Tweedie  R.  Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.   Biometrics. 2000;56(2):455-463. doi:10.1111/j.0006-341X.2000.00455.xPubMedGoogle ScholarCrossref
19.
Adamik  B, Bawiec  M, Bezborodov  V,  et al. Bounds on the total number of SARS-CoV-2 infections: the link between severeness rate, household attack rate and the number of undetected cases. Published August 15, 2020. Accessed November 11, 2020. https://docisolation.prod.fire.glass/?guid=8579b2af-bdb0-4d1f-f538-bc52f86d984e
20.
Arnedo-Pena  A, Sabater-Vidal  S, Meseguer-Ferrer  N,  et al.  COVID-19 secondary attack rate and risk factors in household contacts in Castellon (Spain): preliminary report.   Enfermedades Emergentes. 2020;19(2):64-70. Accessed November 11, 2020. https://docisolation.prod.fire.glass/?guid=45f61a53-bdcc-40ab-ded8-dd9646aa077cGoogle Scholar
21.
Bae  S, Kim  H, Jung  T-Y,  et al.  Epidemiological characteristics of COVID-19 outbreak at fitness centers in Cheonan, Korea.   J Korean Med Sci. 2020;35(31):e288. doi:10.3346/jkms.2020.35.e288PubMedGoogle Scholar
22.
Bi  Q, Wu  Y, Mei  S,  et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.   Lancet Infect Dis. 2020;20(8):911-919. doi:10.1016/S1473-3099(20)30287-5PubMedGoogle ScholarCrossref
23.
Böhmer  MM, Buchholz  U, Corman  VM,  et al.  Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.   Lancet Infect Dis. 2020;20(8):920-928. doi:10.1016/S1473-3099(20)30314-5PubMedGoogle ScholarCrossref
24.
Boscolo-Rizzo  P, Borsetto  D, Spinato  G,  et al.  New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects.   Eur Arch Otorhinolaryngol. 2020;277(9):2637-2640. doi:10.1007/s00405-020-06066-9PubMedGoogle ScholarCrossref
25.
Burke  RM.  Active monitoring of persons exposed to patients with confirmed COVID-19—United States, January-February 2020.   MMWR Morb Mortal Wkly Rep. 2020;69:245-246. doi:10.15585/mmwr.mm6909e1Google ScholarCrossref
26.
Chaw  L, Koh  WC, Jamaludin  SA, Naing  L, Alikhan  MF, Wong  J.  SARS-CoV-2 transmission in different settings: analysis of cases and close contacts from the Tablighi cluster in Brunei Darussalam.   Emerg Infect Dis. 2020;26(11):2598-2606. doi:10.3201/eid2611.202263Google ScholarCrossref
27.
Chen  Y, Wang  AH, Yi  B,  et al.  [Epidemiological characteristics of infection in COVID-19 close contacts in Ningbo city].   Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(5):667-671. doi:10.3760/cma.j.cn112338-20200304-00251PubMedGoogle Scholar
28.
Cheng  HY, Jian  SW, Liu  DP, Ng  TC, Huang  WT, Lin  HH; Taiwan COVID-19 Outbreak Investigation Team.  Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset.   JAMA Intern Med. 2020;180(9):1156-1163. doi:10.1001/jamainternmed.2020.2020PubMedGoogle ScholarCrossref
29.
Dattner  I, Goldberg  Y, Katriel  G,  et al.  The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children.   medRxiv. Preprint published online October 11, 2020. doi:10.1101/2020.06.03.20121145Google Scholar
30.
Dawson  P, Rabold  EM, Laws  RL,  et al.  Loss of taste and smell as distinguishing symptoms of COVID-19.   Clin Infect Dis. 2020;ciaa799. doi:10.1093/cid/ciaa799PubMedGoogle Scholar
31.
Dong  XC, Li  JM, Bai  JY,  et al.  [Epidemiological characteristics of confirmed COVID-19 cases in Tianjin].   Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(5):638-641. doi:10.3760/cma.j.cn112338-20200221-00146PubMedGoogle Scholar
32.
Doung-ngern  P, Suphanchaimat  R, Panjagampatthana  A,  et al.  Case-control study of use of personal protective measures and risk for SARS-CoV 2 infection, Thailand.   Emerg Infect Dis. 2020;26(11):2607-2616. doi:10.3201/eid2611.203003PubMedGoogle ScholarCrossref
33.
Draper  AD, Dempsey  KE, Boyd  RH,  et al.  The first 2 months of COVID-19 contact tracing in the Northern Territory of Australia, March-April 2020.   Commun Dis Intell (2018). 2020;44:44.PubMedGoogle Scholar
34.
Fateh-Moghadam  P, Battisti  L, Molinaro  S,  et al.  Contact tracing during phase I of the COVID-19 pandemic in the Province of Trento, Italy: key findings and recommendations.   medRxiv. Preprint published online July 29, 2020. doi:10.1101/2020.07.16.20127357Google Scholar
35.
Han  T.  Outbreak investigation: transmission of COVID-19 started from a spa facility in a local community in Korea.   Epidemiol Health. 2020;42(0):e2020056-e2020050. doi:10.4178/epih.e2020056PubMedGoogle ScholarCrossref
36.
Hu  S, Wang  W, Wang  Y,  et al.  Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China.   medRxiv. Preprint published online November 3, 2020. doi:10.1101/2020.07.23.20160317Google Scholar
37.
Hua  CZ, Miao  ZP, Zheng  JS,  et al.  Epidemiological features and viral shedding in children with SARS-CoV-2 infection.   J Med Virol. Published online June 15, 2020. doi:10.1002/jmv.26180PubMedGoogle Scholar
38.
Islam  SS, Noman  ASM. Transmission dynamics and contact tracing assessment of COVID-19 in Chattogram, Bangladesh and potential risk of close contacts at different exposure settings. Published October 12, 2020. Accessed November 11, 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3677863
39.
Jing  Q-L, Liu  M-J, Zhang  ZB,  et al.  Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.   Lancet Infect Dis. 2020;20(10):1141-1150. doi:10.1016/S1473-3099(20)30471-0PubMedGoogle ScholarCrossref
40.
Kim  J, Choe  YJ, Lee  J,  et al.  Role of children in household transmission of COVID-19.   Arch Dis Child. 2020;archdischild-2020-319910. doi:10.1136/archdischild-2020-319910PubMedGoogle Scholar
41.
COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention.  Coronavirus disease-19: summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea.   Osong Public Health Res Perspect. 2020;11(2):81-84. doi:10.24171/j.phrp.2020.11.2.04PubMedGoogle ScholarCrossref
42.
Laxminarayan  R, Wahl  B, Dudala  SR,  et al.  Epidemiology and transmission dynamics of COVID-19 in two Indian states.   Science. 2020;370(6517):691-697. doi:10.1126/science.abd7672PubMedGoogle ScholarCrossref
43.
Lee  M, Eun  Y, Park  K, Heo  J, Son  H.  Follow-up investigation of asymptomatic COVID-19 cases at diagnosis in Busan, Korea.   Epidemiol Health. 2020;42:e2020046. doi:10.4178/epih.e2020046PubMedGoogle Scholar
44.
Lewis  NM, Chu  VT, Ye  D,  et al.  Household transmission of SARS-CoV-2 in the United States.   Clin Infect Dis. Published online August 16, 2020. doi:10.1093/cid/ciaa1166Google Scholar
45.
Li  W, Zhang  B, Lu  J,  et al.  Characteristics of household transmission of COVID-19.   Clin Infect Dis. 2020;71(8):1943-1946. doi:10.1093/cid/ciaa450PubMedGoogle ScholarCrossref
46.
Liu  T, Liang  W, Zhong  H,  et al.  Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing.   Emerg Microbes Infect. 2020;9(1):1546-1553. doi:10.1080/22221751.2020.1787799PubMedGoogle ScholarCrossref
47.
Lopez Bernal  J, Panagiotopoulos  N, Byers  C,  et al.  Transmission dynamics of COVID-19 in household and community settings in the United Kingdom.   medRxiv. Preprint published online August 22, 2020. doi:10.1101/2020.08.19.20177188Google Scholar
48.
Luo  L, Liu  D, Liao  X,  et al.  Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study.   Ann Intern Med. Published August 13, 2020. doi:10.7326/M20-2671PubMedGoogle Scholar
49.
Lyngse  FP, Kirkeby  CT, Halasa  T,  et al.  COVID-19 transmission within Danish households: a nationwide study from lockdown to reopening.   medRxiv. Preprint published online September 9, 2020. doi:10.1101/2020.09.09.20191239Google Scholar
50.
Malheiro  R, Figueiredo  AL, Magalhães  JP,  et al.  Effectiveness of contact tracing and quarantine on reducing COVID-19 transmission: a retrospective cohort study.   Public Health. 2020;189:54-59. doi:10.1016/j.puhe.2020.09.012PubMedGoogle ScholarCrossref
51.
Park  YJ, Choe  YJ, Park  O,  et al; COVID-19 National Emergency Response Center, Epidemiology and Case Management Team.  Contact tracing during coronavirus disease outbreak, South Korea, 2020.   Emerg Infect Dis. 2020;26(10):2465-2468. doi:10.3201/eid2610.201315PubMedGoogle ScholarCrossref
52.
Park  SY, Kim  Y-M, Yi  S,  et al.  Coronavirus disease outbreak in call center, South Korea.   Emerg Infect Dis. 2020;26(8):1666-1670. doi:10.3201/eid2608.201274PubMedGoogle ScholarCrossref
53.
Patel  A, Charani  E, Ariyanayagam  D,  et al.  New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.   Clin Microbiol Infect. Published online June 2 2020.PubMedGoogle Scholar
54.
Phiriyasart  F, Chantutanon  S, Salaeh  F,  et al. Outbreak investigation of coronavirus disease (COVID-19) among Islamic missionaries in southern Thailand, April 2020. Outbreak, Surveillance, Investigation, and Response (OSIR) Journal. 2020;13(2). Accessed November 11, 2020. http://www.osirjournal.net/index.php/osir/article/view/195
55.
Rosenberg  ES, Dufort  EM, Blog  DS,  et al; New York State Coronavirus 2019 Response Team.  COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York State—March 2020.   Clin Infect Dis. 2020;71(8):1953-1959. doi:10.1093/cid/ciaa549PubMedGoogle ScholarCrossref
56.
Shah  K, Desai  N, Saxena  D, Mavalankar  D, Mishra  U, Patel  GC.  Household secondary attack rate in Gandhinagar district of Gujarat state from Western India.   medRxiv. Preprint published online September 5, 2020. doi:10.1101/2020.09.03.20187336Google Scholar
57.
Son  H, Lee  H, Lee  M,  et al.  Epidemiological characteristics of and containment measures for COVID-19 in Busan, South Korea.   Epidemiology and Health. 2020;42:e2020035. doi:10.4178/epih.e2020035PubMedGoogle Scholar
58.
Sun  WW, Ling  F, Pan  JR,  et al.  [Epidemiological characteristics of COVID-19 family clustering in Zhejiang Province].   Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(6):625-629. doi:10.3760/cma.j.cn112150-20200227-00199PubMedGoogle Scholar
59.
Teherani  MF, Kao  CM, Camacho-Gonzalez  A,  et al.  Burden of illness in households with SARS-CoV-2 infected children.   J Pediatric Infect Dis Soc. 2020;9(5):613-616. doi:10.1093/jpids/piaa097PubMedGoogle ScholarCrossref
60.
van der Hoek  W, Backer  JA, Bodewes  R,  et al.  [The role of children in the transmission of SARS-CoV-2].   Ned Tijdschr Geneeskd. 2020;164:D5140.PubMedGoogle Scholar
61.
Wang  Z, Ma  W, Zheng  X, Wu  G, Zhang  R.  Household transmission of SARS-CoV-2.   J Infect. 2020;81(1):179-182. doi:10.1016/j.jinf.2020.03.040PubMedGoogle ScholarCrossref
62.
Wang  X, Pan  Y, Zhang  D,  et al.  Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China.   BMC Infect Dis. 2020;20(1):526. doi:10.1186/s12879-020-05251-9PubMedGoogle ScholarCrossref
63.
Wang  Y, Tian  H, Zhang  L,  et al.  Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China.   BMJ Glob Health. 2020;5(5):e002794. doi:10.1136/bmjgh-2020-002794PubMedGoogle Scholar
64.
Wang  X, Zhou  Q, He  Y,  et al.  Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China.   Eur Respir J. 2020;55(6):2000544. doi:10.1183/13993003.00544-2020PubMedGoogle Scholar
65.
Wu  J, Huang  Y, Tu  C,  et al.  Household transmission of SARS-CoV-2, Zhuhai, China, 2020.   Clin Infect Dis. Published online May 11, 2020;ciaa557. doi:10.1093/cid/ciaa557PubMedGoogle Scholar
66.
Wu  Y, Song  S, Kao  Q, Kong  Q, Sun  Z, Wang  B.  Risk of SARS-CoV-2 infection among contacts of individuals with COVID-19 in Hangzhou, China.   Public Health. 2020;185:57-59. doi:10.1016/j.puhe.2020.05.016PubMedGoogle ScholarCrossref
67.
Xin  H, Jiang  F, Xue  A,  et al.  Risk factors associated with occurrence of COVID-19 among household persons exposed to patients with confirmed COVID-19 in Qingdao Municipal, China.   Transbound Emerg Dis. 2020. doi:10.1111/tbed.13743PubMedGoogle Scholar
68.
Yu  HJ, Hu  YF, Liu  XX,  et al.  Household infection: the predominant risk factor for close contacts of patients with COVID-19.   Travel Med Infect Dis. 2020;36:101809. doi:10.1016/j.tmaid.2020.101809PubMedGoogle Scholar
69.
Yung  CF, Kam  KQ, Chong  CY,  et al.  Household transmission of SARS-CoV-2 from adults to children.   J Ped. 2020;225:249-251. doi:10.1016/j.jpeds.2020.07.009Google ScholarCrossref
70.
Zhang  W, Cheng  W, Luo  L,  et al.  Secondary transmission of coronavirus disease from presymptomatic persons, China.   Emerg Infect Dis. 2020;26(8):1924-1926. doi:10.3201/eid2608.201142PubMedGoogle ScholarCrossref
71.
Zhang  JZ, Zhou  P, Han  DB,  et al.  [Investigation on a cluster epidemic of COVID-19 in a supermarket in Liaocheng, Shandong province].   Zhonghua Liu Xing Bing Xue Za Zhi. Published April 27, 2020.PubMedGoogle Scholar
72.
Zhuang  YL, Zhang  YT, Li  M,  et al.  [Analysis on the cluster epidemic of coronavirus disease 2019 in Guangdong Province].   Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(7):720-725.PubMedGoogle Scholar
73.
Stringhini  S, Wisniak  A, Piumatti  G,  et al.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.   Lancet. 2020;396(10247):313-319. doi:10.1016/S0140-6736(20)31304-0PubMedGoogle ScholarCrossref
74.
Yang  K, Wang  L, Li  F,  et al.  Analysis of epidemiological characteristics of coronavirus 2019 infection and preventive measures in Shenzhen China: a heavy population city.   medRxiv. Preprint published online March 3, 2020. doi:10.1101/2020.02.28.20028555Google Scholar
75.
Fontanet  A, Grant  R, Tondeur  L,  et al.  SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission.   medRxiv. Preprint published online June 29, 2020. doi:10.1101/2020.06.25.20140178Google Scholar
76.
Chan  LY, Wong  JT, Li  PK, Lui  SF, Fung  H, Sung  J.  Risk of transmission of severe acute respiratory syndrome to household contacts by infected health care workers and patients.   Am J Med. 2004;116(8):559-560. doi:10.1016/j.amjmed.2003.11.011PubMedGoogle ScholarCrossref
77.
Goh  DL, Lee  BW, Chia  KS,  et al.  Secondary household transmission of SARS, Singapore.   Emerg Infect Dis. 2004;10(2):232-234. doi:10.3201/eid1002.030676PubMedGoogle ScholarCrossref
78.
Lau  JT, Lau  M, Kim  JH, Tsui  HY, Tsang  T, Wong  TW.  Probable secondary infections in households of SARS patients in Hong Kong.   Emerg Infect Dis. 2004;10(2):235-243. doi:10.3201/eid1002.030626PubMedGoogle Scholar
79.
Wilson-Clark  SD, Deeks  SL, Gournis  E,  et al.  Household transmission of SARS, 2003.   CMAJ. 2006;175(10):1219-1223. doi:10.1503/cmaj.050876PubMedGoogle ScholarCrossref
80.
Ou  J, Li  Q, Zeng  G, Dun  Z; Centers for Disease Control and Prevention (CDC).  Efficiency of quarantine during an epidemic of severe acute respiratory syndrome—Beijing, China, 2003.   MMWR Morb Mortal Wkly Rep. 2003;52(43):1037-1040.PubMedGoogle Scholar
81.
Tuan  PA, Horby  P, Dinh  PN,  et al; WHO SARS Investigation Team in Vietnam.  SARS transmission in Vietnam outside of the health-care setting.   Epidemiol Infect. 2007;135(3):392-401. doi:10.1017/S0950268806006996PubMedGoogle ScholarCrossref
82.
Pang  X, Zhu  Z, Xu  F,  et al.  Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003.   JAMA. 2003;290(24):3215-3221. doi:10.1001/jama.290.24.3215PubMedGoogle ScholarCrossref
83.
Al Hosani  FI, Kim  L, Khudhair  A,  et al.  Serologic follow-up of Middle East respiratory syndrome coronavirus cases and contacts—Abu Dhabi, United Arab Emirates.   Clin Infect Dis. 2019;68(3):409-418. doi:10.1093/cid/ciy503PubMedGoogle ScholarCrossref
84.
Arwady  MA, Alraddadi  B, Basler  C,  et al.  Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014.   Emerg Infect Dis. 2016;22(8):1395-1402. doi:10.3201/eid2208.152015PubMedGoogle ScholarCrossref
85.
Assiri  A, McGeer  A, Perl  TM,  et al; KSA MERS-CoV Investigation Team.  Hospital outbreak of Middle East respiratory syndrome coronavirus.   N Engl J Med. 2013;369(5):407-416. doi:10.1056/NEJMoa1306742PubMedGoogle ScholarCrossref
86.
Drosten  C, Meyer  B, Müller  MA,  et al.  Transmission of MERS-coronavirus in household contacts.   N Engl J Med. 2014;371(9):828-835. doi:10.1056/NEJMoa1405858PubMedGoogle ScholarCrossref
87.
Memish  ZA, Al-Tawfiq  JA, Alhakeem  RF,  et al.  Middle East respiratory syndrome coronavirus (MERS-CoV): a cluster analysis with implications for global management of suspected cases.   Travel Med Infect Dis. 2015;13(4):311-314. doi:10.1016/j.tmaid.2015.06.012PubMedGoogle ScholarCrossref
88.
Payne  DC, Biggs  HM, Al-Abdallat  MM,  et al.  Multihospital outbreak of a Middle East respiratory syndrome coronavirus deletion variant, Jordan: a molecular, serologic, and epidemiologic investigation.   Open Forum Infect Dis. 2018;5(5):ofy095. doi:10.1093/ofid/ofy095PubMedGoogle Scholar
89.
Van Kerkhove  MD, Alaswad  S, Assiri  A,  et al.  Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015.   Emerg Infect Dis. 2019;25(10):1802-1809. doi:10.3201/eid2510.190130PubMedGoogle ScholarCrossref
90.
Esposito  S, Bosis  S, Niesters  HG,  et al.  Impact of human coronavirus infections in otherwise healthy children who attended an emergency department.   J Med Virol. 2006;78(12):1609-1615. doi:10.1002/jmv.20745PubMedGoogle ScholarCrossref
91.
Monto  AS, DeJonge  PM, Callear  AP,  et al.  Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan.   J Infect Dis. 2020;222(1):9-16. doi:10.1093/infdis/jiaa161PubMedGoogle ScholarCrossref
92.
Beale  S, Lewer  D, Aldridge  RW,  et al.  Household transmission of seasonal coronavirus infections: results from the Flu Watch cohort study.   Wellcome Open Research. 2020;5(145):145. doi:10.12688/wellcomeopenres.16055.1Google ScholarCrossref
93.
Tsang  TK, Lau  LLH, Cauchemez  S, Cowling  BJ.  Household transmission of influenza virus.   Trends Microbiol. 2016;24(2):123-133. doi:10.1016/j.tim.2015.10.012PubMedGoogle ScholarCrossref
94.
Ministry of Health, Labour, and Welfare. Avoid the “Three Cs”! Accessed August 5, 2020. https://www.mhlw.go.jp/content/10900000/000619576.pdf
95.
Pang  X, Yang  P, Li  S,  et al.  Pandemic (H1N1) 2009 among quarantined close contacts, Beijing, People’s Republic of China.   Emerg Infect Dis. 2011;17(10):1824-1830. doi:10.3201/eid1710.101344PubMedGoogle ScholarCrossref
96.
Tam  K, Yousey-Hindes  K, Hadler  JL.  Influenza-related hospitalization of adults associated with low census tract socioeconomic status and female sex in New Haven County, Connecticut, 2007-2011.   Influenza Other Respir Viruses. 2014;8(3):274-281. doi:10.1111/irv.12231PubMedGoogle ScholarCrossref
97.
Chandrasekhar  R, Sloan  C, Mitchel  E,  et al.  Social determinants of influenza hospitalization in the United States.   Influenza Other Respir Viruses. 2017;11(6):479-488. doi:10.1111/irv.12483PubMedGoogle ScholarCrossref
98.
Sloan  C, Chandrasekhar  R, Mitchel  E, Schaffner  W, Lindegren  ML.  Socioeconomic disparities and influenza hospitalizations, Tennessee, USA.   Emerg Infect Dis. 2015;21(9):1602-1610. doi:10.3201/eid2109.141861PubMedGoogle ScholarCrossref
99.
Viner  RM, Mytton  OT, Bonell  C,  et al.  Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis.   JAMA Pediatr. Published September 25, 2020. doi:10.1001/jamapediatrics.2020.4573PubMedGoogle Scholar
100.
Davies  NG, Klepac  P, Liu  Y, Prem  K, Jit  M, Eggo  RM; CMMID COVID-19 working group.  Age-dependent effects in the transmission and control of COVID-19 epidemics.   Nat Med. 2020;26(8):1205-1211. doi:10.1038/s41591-020-0962-9PubMedGoogle ScholarCrossref
101.
Huang  AT, Garcia-Carreras  B, Hitchings  MDT,  et al.  A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.   Nat Commun. 2020;11(1):4704. doi:10.1038/s41467-020-18450-4PubMedGoogle ScholarCrossref
102.
Mehta  NS, Mytton  OT, Mullins  EWS,  et al.  SARS-CoV-2 (COVID-19): what do we know about children? a systematic review.   Clin Infect Dis. Published May 11, 2020;ciaa556. doi:10.1093/cid/ciaa556PubMedGoogle Scholar
103.
Posfay-Barbe  KM, Wagner  N, Gauthey  M,  et al.  COVID-19 in children and the dynamics of infection in families.   Pediatrics. 2020;146(2):e20201576. doi:10.1542/peds.2020-1576PubMedGoogle Scholar
104.
Lee  B, Raszka  WV  Jr.  COVID-19 transmission and children: the child is not to blame.   Pediatrics. 2020;146(2):e2020004879. doi:10.1542/peds.2020-004879PubMedGoogle Scholar
105.
Zhu  Y, Bloxham  CJ, Hulme  KD,  et al.  Children are unlikely to have been the primary source of household SARS-CoV-2 infections.   medRxiv. Preprint published online March 30, 2020. doi:10.1101/2020.03.26.20044826Google Scholar
106.
L'Huillier  AG, Torriani  G, Pigny  F, Kaiser  L, Eckerle  I.  Culture-competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents.   Emerg Infect Dis. 2020;26(10):2494-2497. doi:10.3201/eid2610.202403Google ScholarCrossref
107.
World Health Organization. Gender and COVID-19. Published May 14, 2020. Accessed November 11, 2020. https://www.who.int/publications/i/item/gender-and-covid-19
108.
Walsh  KA, Jordan  K, Clyne  B,  et al.  SARS-CoV-2 detection, viral load and infectivity over the course of an infection.   J Infect. 2020;81(3):357-371. doi:10.1016/j.jinf.2020.06.067PubMedGoogle ScholarCrossref
109.
He  X, Lau  EHY, Wu  P,  et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19.   Nat Med. 2020;26(5):672-675. doi:10.1038/s41591-020-0869-5PubMedGoogle ScholarCrossref
110.
Ali  ST, Wang  L, Lau  EHY,  et al.  Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions.   Science. 2020;369(6507):1106-1109. doi:10.1126/science.abc9004PubMedGoogle ScholarCrossref
111.
Rabaan  AA, Al-Ahmed  SH, Haque  S,  et al.  SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview.   Infez Med. 2020;28(2):174-184.PubMedGoogle Scholar
112.
Petersen  E, Koopmans  M, Go  U,  et al.  Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.   Lancet Infect Dis. 2020;20(9):e238-e244. doi:10.1016/S1473-3099(20)30484-9PubMedGoogle ScholarCrossref
113.
Petrosillo  N, Viceconte  G, Ergonul  O, Ippolito  G, Petersen  E.  COVID-19, SARS and MERS: are they closely related?   Clin Microbiol Infect. 2020;26(6):729-734. doi:10.1016/j.cmi.2020.03.026PubMedGoogle ScholarCrossref
114.
Fraser  C, Riley  S, Anderson  RM, Ferguson  NM.  Factors that make an infectious disease outbreak controllable.   Proc Natl Acad Sci U S A. 2004;101(16):6146-6151. doi:10.1073/pnas.0307506101PubMedGoogle ScholarCrossref
115.
Cowling  BJ, Park  M, Fang  VJ, Wu  P, Leung  GM, Wu  JT.  Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015.   Euro Surveill. 2015;20(25):7-13. doi:10.2807/1560-7917.ES2015.20.25.21163PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    5 Comments for this article
    EXPAND ALL
    Question
    Larry Martinez, N/A | N/A
    "Household secondary attack rates were increased from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) than from asymptomatic index cases (0.7%; 95% CI, 0%-4.9%)..."

    Does that mean that if someone in my household is symptomatic, I have an 18% chance to contract the virus? And a .7% chance to contract it from an asymptomatic household member?
    CONFLICT OF INTEREST: None Reported
    Response to Larry Martinez
    Alfred Stolfa, BE, Cert IV Public Safety | None
    Larry,

    Regarding your question:

    "Does that mean that if someone in my household is symptomatic, I have an 18% chance to contract the virus? And a .7% chance to contract it from an asymptomatic household member?"

    The percentages quoted are based on analysis of metadata, not the specific risk profile anyone of us may experience in their own home should a member of our family be living there while infectious with SARS-CoV-2 (COVID-19). The nuances and wide variability in human behaviours cannot be possibly accounted for in such a retrospective metadata study because the study's authors do
    not have access to all the individuals to confirm the exact circumstances of their contact with infected parties.

    If the infectious individual remained quarantine in a single room and instances of direct or close proximity contact were ruled out, meals/ablutions were taken in isolation from other family members, all surfaces in common areas (bathroom, kitchen, etc.) were regularly wiped down after the infected person accessed them, and all individuals work masks, YOUR risk of contracting the infection would be significantly less than if none of these measures were in place and the infected individual roamed the house and interacted with family members in a 'business as usual' manner.

    Hope this helps.
    CONFLICT OF INTEREST: None Reported
    READ MORE
    statistical error?
    Jeffrey Archinal, MD | Akron Children's Hospital, Akron, OH
    I'll admit I'm a primary care doc and not a researcher, but I would like help understanding how one could conclude from the 4 studies of asymptomatic people that there's a 0.7% secondary attack rate? One study had 6 positives out of 111 contacts (5.4%), another has 1 out of 23 (4.3%), another had 0 out of 15, and finally 0 out of 2.

    I know there's more statistics going on then crudely adding up the numbers, but for a simple PCP crudely adding up the numbers, that looks like we have 7 positives out of 151 contacts, or
    4.6%. How does one get from here to the reported 0.7%? If it's some weird statistical thing involving the tiny studies of 2 and 15 contacts, especially if we're talking about an event that only happens 0.7-4.6% of the time, I'm curious if they are worth including in the analysis?

    The decision to include those studies resulted in a somewhat-popular political commentator using this finding to say masks don't work, since the secondary attack rate in this study wasn't found to be statistically different from 0. This study is making people feel justified to not wear a mask, and I don't see any way this finding could have been reached except by a mistake, either as a result of a flat-out miscalculation, or a faulty decision to include two tiny studies that skewed the numbers.
    CONFLICT OF INTEREST: None Reported
    READ MORE
    Secondary attack rates in the asymptomatic subgroup
    Stephen Friedman, MD, MPH |
    In supplemental figure 8, the authors presented four studies with secondary attack rates of 6/111, 1/23, 0/2 and 0/15.
    Based on the random effects model multivariable analysis, they estimated the transmission rate as 0.7%. Can the authors explain how the significant variables in the model affected the calculation of the transmission rate to produce an estimate different from the rates in the four studies? Can the authors also comment on whether these four studies (three with sample size less than 25) provide a reliable estimate of the secondary attack rate from asymptomatic individuals?
    Stephen Friedman, MD, MPH
    CONFLICT OF INTEREST: None Reported
    Comment from the authors
    Zachary Madewell, PhD, MPH | University of Florida
    Thank you for your interest in our paper. In this sub-analysis of the household studies from our main analysis, we separated papers reporting index cases identified as symptomatic versus asymptomatic/pre-symptomatic. We noted lower transmission from this latter group, though we state that there was much less data. For this reason, we view the qualitative result as noteworthy but requiring further exploration. Since we relied upon other studies in the literature, we were unable to separate out fully asymptomatic index cases (who never develop symptoms) from pre-symptomatic index cases. A more recent meta-analysis has focused directly on separating these two groups (https://pubmed.ncbi.nlm.nih.gov/33484843/). The growing literature indicates that, while individuals can be similarly infectious during the pre-symptomatic and symptomatic phases, individuals who are fully asymptomatic are less infectious to others (summary secondary attack rate of 1% from Qiu et al. 2021). This may explain the low secondary attack rate we observed in our sub-analysis.

    Regarding the methods used to calculate our point estimate, we used a restricted maximum-likelihood estimator model to yield Freeman-Tukey double arcsine–transformed point estimates and 95% CI for secondary attack rate for each subgroup analyzed, with a random effect for each study. This method is often used in meta-analyses and was recently used in another study describing asymptomatic transmission of SARS-CoV-2 (https://pubmed.ncbi.nlm.nih.gov/33484843/). When estimates are near zero, the Freeman-Tukey double arcsine–transformation can weight the point estimate more heavily towards zero than other methods. Other methods would return a point estimate closer to the raw combined proportion, but the qualitative conclusion of lower transmission would be the same.
    CONFLICT OF INTEREST: None Reported
    READ MORE
    Original Investigation
    Global Health
    December 14, 2020

    Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis

    Author Affiliations
    • 1Department of Biostatistics, University of Florida, Gainesville
    • 2Fred Hutchinson Cancer Research Center, Seattle, Washington
    • 3Department of Biostatistics, University of Washington, Seattle
    JAMA Netw Open. 2020;3(12):e2031756. doi:10.1001/jamanetworkopen.2020.31756
    Key Points

    Question  What is the household secondary attack rate for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?

    Findings  In this meta-analysis of 54 studies with 77 758 participants, the estimated overall household secondary attack rate was 16.6%, higher than observed secondary attack rates for SARS-CoV and Middle East respiratory syndrome coronavirus. Controlling for differences across studies, secondary attack rates were higher in households from symptomatic index cases than asymptomatic index cases, to adult contacts than to child contacts, to spouses than to other family contacts, and in households with 1 contact than households with 3 or more contacts.

    Meaning  These findings suggest that households are and will continue to be important venues for transmission, even in areas where community transmission is reduced.

    Abstract

    Importance  Crowded indoor environments, such as households, are high-risk settings for the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

    Objectives  To examine evidence for household transmission of SARS-CoV-2, disaggregated by several covariates, and to compare it with other coronaviruses.

    Data Source  PubMed, searched through October 19, 2020. Search terms included SARS-CoV-2 or COVID-19 with secondary attack rate, household, close contacts, contact transmission, contact attack rate, or family transmission.

    Study Selection  All articles with original data for estimating household secondary attack rate were included. Case reports focusing on individual households and studies of close contacts that did not report secondary attack rates for household members were excluded.

    Data Extraction and Synthesis  Meta-analyses were done using a restricted maximum-likelihood estimator model to yield a point estimate and 95% CI for secondary attack rate for each subgroup analyzed, with a random effect for each study. To make comparisons across exposure types, study was treated as a random effect, and exposure type was a fixed moderator. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline was followed.

    Main Outcomes and Measures  Secondary attack rate for SARS-CoV-2, disaggregated by covariates (ie, household or family contact, index case symptom status, adult or child contacts, contact sex, relationship to index case, adult or child index cases, index case sex, number of contacts in household) and for other coronaviruses.

    Results  A total of 54 relevant studies with 77 758 participants reporting household secondary transmission were identified. Estimated household secondary attack rate was 16.6% (95% CI, 14.0%-19.3%), higher than secondary attack rates for SARS-CoV (7.5%; 95% CI, 4.8%-10.7%) and MERS-CoV (4.7%; 95% CI, 0.9%-10.7%). Household secondary attack rates were increased from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) than from asymptomatic index cases (0.7%; 95% CI, 0%-4.9%), to adult contacts (28.3%; 95% CI, 20.2%-37.1%) than to child contacts (16.8%; 95% CI, 12.3%-21.7%), to spouses (37.8%; 95% CI, 25.8%-50.5%) than to other family contacts (17.8%; 95% CI, 11.7%-24.8%), and in households with 1 contact (41.5%; 95% CI, 31.7%-51.7%) than in households with 3 or more contacts (22.8%; 95% CI, 13.6%-33.5%).

    Conclusions and Relevance  The findings of this study suggest that given that individuals with suspected or confirmed infections are being referred to isolate at home, households will continue to be a significant venue for transmission of SARS-CoV-2.

    Introduction

    The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is spread via direct or indirect contact with infected people via infected respiratory droplets or saliva, fomites, or aerosols.1,2 Crowded indoor environments with sustained close contact and conversations, such as households, are a particularly high-risk setting.3

    The World Health Organization China Joint Mission reported human-to-human transmission in China largely occurred within families, accounting for 78% to 85% of clusters in Guangdong and Sichuan provinces.4 Stay-at-home orders reduced human mobility by 35% to 63% in the United States,5 63% in the United Kingdom,6 and 54% in Wuhan,7 relative to normal conditions, which concomitantly increased time at home. Modeling studies demonstrated that household transmission had a greater relative contribution to the basic reproductive number after social distancing (30%-55%) than before social distancing (5%-35%).8 While current US Centers for Disease Control and Prevention recommendations are to maintain 6 feet of distance from a sick household member, this may be difficult to achieve in practice and not be fully effective.9

    The household secondary attack rate characterizes virus transmissibility. Studies can collect detailed data on type, timing, and duration of contacts and identify risk factors associated with infectiousness of index cases and susceptibility of contacts. Our objective was to estimate the secondary attack rate of SARS-CoV-2 in households and determine factors that modify this parameter. We also estimated the proportion of households with index cases that had any secondary transmission. Furthermore, we compared the SARS-CoV-2 household secondary attack rate with that of other severe viruses and with that to close contacts for studies that reported the secondary attack rate for both close and household contacts.

    Methods
    Definitions

    We estimated the transmissibility of SARS-CoV-2 within the household or family by the empirical secondary attack rate by dividing the number of new infections among contacts by the total number of contacts. Household contacts include anyone living in the same residence as the index case. Family contacts include the family members of index cases, including individuals who live outside the index case’s household. Close contact definitions varied by study and included physical proximity to an index case, exceeding a minimum contact time, and/or not wearing effective protection around index cases before the index case was tested.

    Search Strategy

    Following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline, we searched PubMed using terms including SARS-CoV-2 or COVID-19 with secondary attack rate, household, close contacts, contact transmission, contact attack rate, or family transmission (eTable 1 in the Supplement) with no restrictions on language, study design, time, or place of publication. The last search was conducted October 19, 2020.

    Eligibility Criteria

    Eligibility criteria are described in eAppendix 1 in the Supplement. All articles with original data for estimating household secondary attack rate were included. Case reports focusing on individual households and studies of close contacts that did not report secondary attack rates for household members were excluded.

    Data Extraction

    One of us (Z.J.M.) extracted data from each study. Details appear in eAppendix 2 in the Supplement.

    Evaluation of Study Quality and Risk of Bias

    To assess the methodological quality and risk of bias of included studies of SARS-CoV-2, we used the same modified version of the Newcastle-Ottawa quality assessment scale for observational studies used by Fung et al.10,11 Studies received as many as 9 points based on participant selection (4 points), study comparability (1 point), and outcome of interest (4 points). Studies were classified as having high (≤3 points), moderate (4-6 points), and low (≥7 points) risk of bias. One of us (Z.J.M.) evaluated the study quality and assigned the quality grades.

    Statistical Analysis

    Meta-analyses were done using a restricted maximum-likelihood estimator model to yield Freeman-Tukey double arcsine–transformed point estimates and 95% CI for secondary attack rate for each subgroup analyzed, with a random effect for each study.12 For comparisons across covariates (ie, household or family, index case symptom status, adult or child contacts, contact sex, relationship to index case, adult or child index cases, index case sex, number of household contacts, study location, universal or symptomatic testing, dates of study) and comparisons with close contacts and other viruses, study was treated as a random effect, and the covariate was a fixed moderator. Variables had to have been collected in at least 3 studies to be included in meta-analyses. The Cochran Q test and I2 statistic are reported as measures of heterogeneity. I2 values of 25%, 50%, and 75% indicated low, moderate, and high heterogeneity, respectively.13 Stastistical significance was set at a 2-tailed α = .05. All analyses were done in R version 4.0.2 using the package metafor (R Project for Statistical Computing).14,15

    When at least 10 studies were available, we used funnel plots, Begg correlation, and Egger test to evaluate publication bias, with significance set at P < .10.16,17 If we detected publication bias, we used the Duval and Tweedie trim-and-fill approach for adjustment.18

    Results

    We identified 54 relevant published studies that reported household secondary transmission, with 77 758 participants (eTable 1 in the Supplement).19-72 A total of 16 of 54 studies (29.6%) were at high risk of bias, 27 (50.0%) were moderate, and 11 (20.4%) were low (eTable 2 in the Supplement). Lower quality was attributed to studies with 1 or fewer test per contact (35 studies [64.8%]), small sample sizes (31 [57.4%]), and secondary attack rate not disaggregated by covariates (28 [51.9%]).

    A description of index case identification period and methods and symptom status is provided in eTable 3 in the Supplement. Most studies did not describe how co–primary index cases were handled or whether secondary infections could have been acquired from outside the household, both of which can inflate the empirical secondary attack rate. Testing and monitoring strategies varied between studies, often reflecting variations in local testing guidelines implemented as part of contact tracing (eTable 4 and eAppendix 3 in the Supplement).

    Figure 1 summarizes secondary attack rates for 44 studies19-26,28-30,32-36,38-45,47-57,59,61-63,65-67,69,70 of household contacts and 10 of family contacts.26,31,37,45,58,60,65,68,71,72 Estimated mean secondary attack rate for household contacts was 16.4% (95% CI, 13.4%-19.6%) and family contacts was 17.4% (95% CI, 12.7%-22.5%). One study40 restricted index cases to children (age <18 years), resulting in a substantially lower secondary attack rate of 0.5%. Excluding this outlier, the combined secondary attack rate for household and family contacts was 17.1% (95%, 14.6%-19.7%). Secondary attack rates for household and family contacts were more than 3 times higher than for close contacts (4.8%; 95% CI, 3.4%-6.5%; P < .001) (eFigure 2 in the Supplement). Significant heterogeneity was found among studies of household (I2 = 96.9%; P < .001), family (I2 = 93.0%; P < .001), and close (I2 = 97.0%; P < .001) contacts. No significant publication bias was observed for studies of household, family, or close contacts (eFigure 3 in the Supplement). Secondary attack rates were not significantly different when restricting to 38 studies19,20,22,23,26-31,34-40,42,44-51,54-57,60,62,63,65,67-69,72 with low or moderate risk of bias (15.6%; 95%, 12.8%-18.5%) (eFigure 4 in the Supplement). There were no significant differences in secondary attack rates between 21 studies in China22,27,31,36,37,39,45,46,48,58,61-68,70-72 and 33 studies from other countries19-21,23-26,28-30,32-35,38,40-44,47,49-57,59,60,69 (eFigure 5 in the Supplement), 18 studies that tested symptomatic contacts19-21,24,25,28,29,33,34,41,47,50,53,56,58,59,61,64 and 33 studies that reported testing all contacts22,23,26,27,30,31,35-40,42-46,48,49,51,52,54,55,57,60,63,65-67,69-72 (eFigure 6 in the Supplement), and 16 early studies22,23,25,31,37,39,45,58,61,63-66,68,71,72 (January-February) and 20 later studies19,24,26,29,30,32-35,38,42,44,50,53-56,59,60,69 (March-July) (eFigure 7 in the Supplement).

    To study the transmissibility of asymptomatic SARS-CoV-2 index cases, eFigure 8 in the Supplement summarizes 27 studies19-21,23-26,30,32-34,44,45,47,50,52-54,56,59-61,63,64,68,69,72 reporting household secondary attack rates from symptomatic index cases and 4 studies26,43,44,52 from asymptomatic or presymptomatic index cases. Estimated mean household secondary attack rate from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) was significantly higher than from asymptomatic or presymptomatic index cases (0.7%; 95% CI, 0%-4.9%; P < .001), although there were few studies in the latter group. These findings are consistent with other household studies28,70 reporting asymptomatic index cases as having limited role in household transmission.

    There is evidence for clustering of SARS-CoV-2 infections within households, with some households having many secondary infections while many others have none.73-75 For example, 1 study55 reported that 26 of 103 (25.2%) households had all members test positive. This is consistent with observation of overdispersion in the number of secondary cases per index case across a range of settings.3 While most studies reported only the average number of secondary infections per index case, some also reported transmission by household.44,55,56,63,65,69 Figure 2 summarizes the proportion of households with any secondary transmission. Using an empirical analysis based on secondary attack rates and mean number of contacts per household, we found the proportion of households with any secondary transmission was lower than expected in a setting with no clustering (eg, most transmission is not characterized by a minority of infected individuals) (eTable 5 in the Supplement). Ideally, future studies will assess this formally by fitting a β binomial to quantify overdispersion in the full data.

    A number of studies examined factors associated with susceptibility of household contacts to infection (eTable 6 in the Supplement). Age was the most examined covariate, with most studies20,29,36-39,45,46,48,49,55,63,65,68 reporting lower secondary transmission of SARS-CoV-2 to child contacts than adult contacts. In 5 studies,20,36,39,48,49 individuals older than 60 years were most susceptible to SARS-CoV-2 infection. Contact age was not associated with susceptibility in 9 studies,26,28,32,44,47,58,66,67,70 although these were typically less powered to detect a difference. Figure 3 summarizes 15 studies22,26,29,37,39,42,44,45,47,49,55,59,60,63,65 reporting separate secondary attack rates to children and adult contacts. The estimated mean household secondary attack rate was significantly higher to adult contacts (28.3%; 95% CI, 20.2%-37.1%) than to child contacts (16.8%; 95% CI, 12.3%-21.7%; P < .001). Significant heterogeneity was found among studies of adult (I2 = 96.8%; P < .001) and child contacts (I2 = 78.9%; P < .001). Begg (P = .03) and Egger (P = .03) tests were statistically significant for studies of adult but not child contacts (eFigure 9 in the Supplement). One study of adults63 had a high secondary attack rate in the forest plot. Excluding this study improved the funnel plot symmetry and resulted in a secondary attack rate to adult contacts of 26.3% (95% CI, 19.3%-33.2%).

    The second most examined factor was sex of exposed contacts, which was not associated with susceptibility for most studies20,22,26,32,36,39,44,45,47-49,58,65-67,70 except 3.38,46,68 eFigure 10 in the Supplement summarizes results from 11 studies20,39,42,44,45,47,49,58,65,67,69 reporting household secondary attack rates by contact sex. Estimated mean household secondary attack rate to female contacts (20.7%; 95% CI, 15.0%-26.9%) was not significantly different than to male contacts (17.7%; 95% CI, 12.4%-23.8%). Significant heterogeneity was found among studies of female contacts (I2 = 87.4%; P < .001) and male contacts (I2 = 87.7%; P < .001). Moderate asymmetry was observed in the funnel plots, which was significant for studies of female contacts from Egger test (P = .07) but not male contacts (eFigure 11 in the Supplement). However, imputation of an adjusted effect size using the trim-and-fill method did not significantly change the secondary attack rate to female contacts (19.7%; 95% CI, 13.9%-25.6%).

    Spouse relationship to index case was associated with secondary infection in 4 studies26,45,46,58 of 6 in which this was examined.65,67 Infection risk was highest for spouses, followed by nonspouse family members and other relatives, which were all higher than other contacts.46 Figure 4 summarizes results from 7 studies26,44-46,58,65,67 reporting household secondary attack rates by relationship. Estimated mean household secondary attack rate to spouses (37.8%; 95% CI, 25.8%-50.5%) was significantly higher than to other contacts (17.8%; 95% CI, 11.7%-24.8%). Significant heterogeneity was found among studies of spouses (I2 = 78.6%; P < .001) and other relationships (I2 = 83.5%; P < .001).

    Several studies examined factors associated with infectiousness of index cases. Older index case age was associated with increased secondary infections in 3 studies20,47,67 of 9 in which this was examined.22,36,39,44,63,65 eFigure 12 in the Supplement summarizes results from 3 studies42,44,51 reporting household secondary attack rates by index case age. Estimated mean household secondary attack rate from adults (15.2%; 95% CI, 6.2%-27.4%) was not significantly different than that from children (7.9%; 95% CI, 1.7%-16.8%). Index case sex was associated with transmission in 3 studies42,44,67 of 9 in which this was examined.20,36,45,47,63,65 eFigure 13 in the Supplement summarizes results from 7 studies20,42,44,45,65,67,69 reporting household secondary attack rates by index case sex. Estimated mean household secondary attack rate from female contacts (16.6%; 95% CI, 11.2%-22.8%) was not significantly different than from male contacts (16.4%; 95% CI, 9.0%-25.5%).

    Critically severe index case symptoms was associated with higher infectiousness in 6 studies20,38,46-48,67 of 9 in which this was examined.44,63,70 Index case cough was associated with infectivity in 2 studies 20,65 of 8 in which this was examined45-48,63,67 (eAppendix 4 in the Supplement).

    Contact frequency with the index case was associated with higher odds of infection, specifically at least 5 contacts during 2 days before the index case was confirmed,70 at least 4 contacts and 1 to 3 contacts,63 or frequent contact within 1 meter.22,67,68 Smaller households were associated with transmission in 4 studies20,39,47,49 of 7 in which this was examined.55,63,65 Figure 5 summarizes results from 6 studies20,47,49,55,61,65 reporting household secondary attack rates by number of contacts in the household. Estimated mean household secondary attack rate for households with 1 contact (41.5%; 95% CI, 31.7%-51.7%) was significantly higher than households with at least 3 contacts (22.8%; 95% CI, 13.6%-33.5%; P < .001) but not different than households with 2 contacts (38.6%; 95% CI, 17.9%-61.6%). There was significant heterogeneity in secondary attack rates between studies with 1 contact (I2 = 52.9%; P = .049), 2 contacts (I2 = 93.6%; P < .001), or 3 or more contacts (I2 = 91.6%; P < .001). Information was not available on household crowding (eg, number of people per room).

    eFigure 14 in the Supplement summarizes 7 studies76-82 reporting household secondary attack rates for SARS-CoV, and 7 studies83-89 for Middle East respiratory syndrome coronavirus (MERS-CoV). Estimated mean household secondary attack rate was 7.5% (95% CI, 4.8%-10.7%) for SARS-CoV and 4.7% (95% CI, 0.9%-10.7%) for MERS-CoV (eTable 7 in the Supplement), both lower than the household secondary attack rate of 16.6% for SARS-CoV-2 in this study (P < .001). The SARS-CoV-2 secondary attack rate was also higher than secondary attack rates reported for HCoV-NL63 (0-12.6%), HCoV-OC43 (10.6-13.2%), HCoV-229E (7.2-14.9%), and HCoV-HKU1 (8.6%).90-92 Household secondary attack rates for SARS-CoV-2 were within the mid-range of household secondary attack rates reported for influenza, which ranged from 1% to 38% based on polymerase chain reaction–confirmed infection.93

    Discussion

    We synthesized the available evidence on household studies of SARS-CoV-2. The combined household and family secondary attack rate was 16.6% (95% CI, 14.0%-19.3%), although with significant heterogeneity between studies. This point estimate is higher than previously observed secondary attack rates for SARS-CoV and MERS-CoV. Households are favorable environments for transmission. They are what are known as 3Cs environments, as they are closed spaces, where family members may crowd and be in close contact with conversation.94 There may be reduced use of personal protective equipment relative to other settings.

    That secondary attack rates were not significantly different between household and family contacts may indicate that most family contacts are in the same household as index cases. Household and family contacts are at higher risk than other types of close contacts, and risks are not equal within households. Spouses were at higher risk than other family contacts, which may explain why the secondary attack rate was higher in households with 1 vs 3 or greater contacts. Spouse relationship to the index case was also a significant risk factor observed in studies of SARS-CoV and H1N1.82,95 This may reflect intimacy, sleeping in the same room, or longer or more direct exposure to index cases. Further investigation is required to determine whether sexual contact is a transmission route. Although not directly assessed, household crowding (eg, number of people per room) may be more important for SARS-CoV-2 transmission than the total number of people per household, as has been demonstrated for influenza.96-98

    The finding that secondary attack rates were higher to adult contacts than to child contacts is consistent with empirical and modeling studies.99,100 Lower infection rates in children may be attributed to asymptomatic or mild disease, reduced susceptibility from cross-immunity from other coronaviruses,101 and low case ascertainment,102 but the difference persisted in studies in which all contacts were tested regardless of symptoms. Higher transmission rates to adults may be influenced by spousal transmission. Given the increased risk to spousal contacts, future studies might compare child contacts and nonspouse adult contacts to ascertain whether this difference persists. Limited data suggest children have not played a substantive role in household transmission of SARS-CoV-2.40,103-105 However, a study in South Korea of 10 592 household contacts noted relatively high transmission from index cases who were aged 10 to 19 years.51 Although children seem to be at reduced risk for symptomatic disease, it is still unclear whether they shed virus similarly to adults.106

    We did not find associations between household contact or index case sex and secondary transmission. The World Health Organization reports roughly even distribution of SARS-CoV-2 infections between women and men worldwide, with higher mortality in men.107

    We found significantly higher secondary attack rates from symptomatic index cases than asymptomatic or presymptomatic index cases, although less data were available on the latter. The lack of substantial transmission from observed asymptomatic index cases is notable. However, presymptomatic transmission does occur, with some studies reporting the timing of peak infectiousness at approximately the period of symptom onset.108,109 In countries where infected individuals were isolated outside the home, this could further alter the timing of secondary infections by limiting contacts after illness onset.110

    Household secondary attack rates were higher for SARS-CoV-2 than SARS-CoV and MERS-CoV, which may be attributed to structural differences in spike proteins,111 higher basic reproductive rates,112 and higher viral loads in the nose and throat at the time of symptom onset.113 Symptoms associated with MERS-CoV and SARS-CoV often require hospitalization, which increases nosocomial transmission, whereas less severe symptoms of SARS-CoV-2 facilitate community transmission.113 Similarly, presymptomatic transmission was not observed for MERS-CoV or SARS-CoV.114,115

    Limitations

    Our study had several limitations. The most notable is the large amount of unexplained heterogeneity across studies. This is likely attributable to variability in study definitions of index cases and household contacts, frequency and type of testing, sociodemographic factors, household characteristics (eg, density, air ventilation), and local policies (eg, centralized isolation). Rates of community transmission also varied across locations. Given that studies cannot always rule out infections from outside of the home (eg, nonhousehold contacts), household transmission may be overestimated. For this reason, we excluded studies that used antibody tests to diagnose household contacts. Furthermore, many analyses ignored tertiary transmission within the household, classifying all subsequent cases as secondary to the index case. Eighteen studies19-21,24,25,28,29,33,34,41,47,50,53,56,58,59,61,64 involved testing only symptomatic household contacts, which would miss asymptomatic or subclinical infections, although secondary attack rate estimates were similar across studies testing all vs only symptomatic contacts.

    Important questions remain regarding household spread of SARS-CoV-2. Chief among them is the infectiousness of children to their household contacts and the infectiousness of asymptomatic, mildly ill, and severely ill index cases. This study did not provide additional elucidation of factors influencing intergenerational spread. People unable to work at home may have greater risk of SARS-CoV-2 exposure, which may increase transmission risk to other household members. There may be overdispersion in the number of secondary infections per index case, which could be caused by variations in viral shedding, household ventilation, or other factors.

    Conclusions

    The findings of this study suggest that households are and will continue to be important venues for transmission, even where community transmission is reduced. Prevention strategies, such as increased mask-wearing at home, improved ventilation, voluntary isolation at external facilities, and targeted antiviral prophylaxis, should be further explored.

    Back to top
    Article Information

    Accepted for Publication: November 6, 2020.

    Published: December 14, 2020. doi:10.1001/jamanetworkopen.2020.31756

    Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Madewell ZJ et al. JAMA Network Open.

    Corresponding Author: Zachary J. Madewell, Department of Biostatistics, University of Florida, PO Box 117450, Gainesville, FL 32611 (zmadewell@ufl.edu).

    Author Contributions: Drs Madewell and Dean had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

    Concept and design: Madewell, Longini, Dean.

    Acquisition, analysis, or interpretation of data: All authors.

    Drafting of the manuscript: Madewell, Longini, Dean.

    Critical revision of the manuscript for important intellectual content: All authors.

    Statistical analysis: All authors.

    Obtained funding: Dean.

    Administrative, technical, or material support: Dean.

    Supervision: Dean.

    Conflict of Interest Disclosures: None reported.

    Funding/Support: This work was supported by grant R01-AI139761 from the National Institutes of Health.

    Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

    References
    1.
    World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions. Published July 9, 2020. Accessed November 11, 2020. https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions
    2.
    Oran  DP, Topol  EJ.  Prevalence of asymptomatic SARS-CoV-2 infection : a narrative review.   Ann Intern Med. 2020;173(5):362-367. doi:10.7326/M20-3012PubMedGoogle ScholarCrossref
    3.
    Nishiura  H, Oshitani  H, Kobayashi  T,  et al.  Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19).   medRxiv. Preprint published online April 16, 2020. doi:10.1101/2020.02.28.20029272Google Scholar
    4.
    World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February 16-24, 2020. Accessed November 11, 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
    5.
    Badr  HS, Du  H, Marshall  M, Dong  E, Squire  MM, Gardner  LM.  Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study.   Lancet Infect Dis. 2020;20(11):1247-1254. doi:10.1016/S1473-3099(20)30553-3PubMedGoogle ScholarCrossref
    6.
    Drake  TM, Docherty  AB, Weiser  TG, Yule  S, Sheikh  A, Harrison  EM.  The effects of physical distancing on population mobility during the COVID-19 pandemic in the UK.   Lancet Digit Health. 2020;2(8):e385-e387. doi:10.1016/S2589-7500(20)30134-5PubMedGoogle ScholarCrossref
    7.
    Fang  H, Wang  L, Yang  Y. Human mobility restrictions and the spread of the novel coronavirus (2019-nCoV) in China. National Bureau of Economic Research. Published March 2020. Accessed November 11, 2020. https://www.nber.org/papers/w26906
    8.
    Curmei  M, Ilyas  A, Evans  O, Steinhardt  J.  Estimating household transmission of SARS-CoV-2.   medRxiv. Preprint published online June 27, 2020. doi:10.1101/2020.05.23.20111559Google Scholar
    9.
    US Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): how to protect yourself and others. Updated November 4, 2020. Accessed November 11, 2020. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
    10.
    Wells  G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Accessed November 11, 2020. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
    11.
    Fung  HF, Martinez  L, Alarid-Escudero  F,  et al; SC-COSMO Modeling Group.  The household secondary attack rate of SARS-CoV-2: a rapid review.   Clin Infect Dis. Published online October 12, 2020:ciaa1558. doi:10.1093/cid/ciaa1558PubMedGoogle Scholar
    12.
    Freeman  MF, Tukey  JW.  Transformations related to the angular and the square root.   Annals Math Stat. 1950;21(4):607-611. doi:10.1214/aoms/1177729756Google ScholarCrossref
    13.
    Higgins  JP, Thompson  SG, Deeks  JJ, Altman  DG.  Measuring inconsistency in meta-analyses.   BMJ. 2003;327(7414):557-560. doi:10.1136/bmj.327.7414.557PubMedGoogle ScholarCrossref
    14.
    Viechtbauer  W.  Conducting meta-analyses in R with the metafor package.   J Stat Software. 2010;36(3):1-48. doi:10.18637/jss.v036.i03Google ScholarCrossref
    15.
    R Core Team. R: a language and environment for statistical computing. Accessed November 13, 2020. https://www.gbif.org/tool/81287/r-a-language-and-environment-for-statistical-computing
    16.
    Begg  CB, Mazumdar  M.  Operating characteristics of a rank correlation test for publication bias.   Biometrics. 1994;50(4):1088-1101. doi:10.2307/2533446PubMedGoogle ScholarCrossref
    17.
    Egger  M, Davey Smith  G, Schneider  M, Minder  C.  Bias in meta-analysis detected by a simple, graphical test.   BMJ. 1997;315(7109):629-634. doi:10.1136/bmj.315.7109.629PubMedGoogle ScholarCrossref
    18.
    Duval  S, Tweedie  R.  Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.   Biometrics. 2000;56(2):455-463. doi:10.1111/j.0006-341X.2000.00455.xPubMedGoogle ScholarCrossref
    19.
    Adamik  B, Bawiec  M, Bezborodov  V,  et al. Bounds on the total number of SARS-CoV-2 infections: the link between severeness rate, household attack rate and the number of undetected cases. Published August 15, 2020. Accessed November 11, 2020. https://docisolation.prod.fire.glass/?guid=8579b2af-bdb0-4d1f-f538-bc52f86d984e
    20.
    Arnedo-Pena  A, Sabater-Vidal  S, Meseguer-Ferrer  N,  et al.  COVID-19 secondary attack rate and risk factors in household contacts in Castellon (Spain): preliminary report.   Enfermedades Emergentes. 2020;19(2):64-70. Accessed November 11, 2020. https://docisolation.prod.fire.glass/?guid=45f61a53-bdcc-40ab-ded8-dd9646aa077cGoogle Scholar
    21.
    Bae  S, Kim  H, Jung  T-Y,  et al.  Epidemiological characteristics of COVID-19 outbreak at fitness centers in Cheonan, Korea.   J Korean Med Sci. 2020;35(31):e288. doi:10.3346/jkms.2020.35.e288PubMedGoogle Scholar
    22.
    Bi  Q, Wu  Y, Mei  S,  et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.   Lancet Infect Dis. 2020;20(8):911-919. doi:10.1016/S1473-3099(20)30287-5PubMedGoogle ScholarCrossref
    23.
    Böhmer  MM, Buchholz  U, Corman  VM,  et al.  Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.   Lancet Infect Dis. 2020;20(8):920-928. doi:10.1016/S1473-3099(20)30314-5PubMedGoogle ScholarCrossref
    24.
    Boscolo-Rizzo  P, Borsetto  D, Spinato  G,  et al.  New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects.   Eur Arch Otorhinolaryngol. 2020;277(9):2637-2640. doi:10.1007/s00405-020-06066-9PubMedGoogle ScholarCrossref
    25.
    Burke  RM.  Active monitoring of persons exposed to patients with confirmed COVID-19—United States, January-February 2020.   MMWR Morb Mortal Wkly Rep. 2020;69:245-246. doi:10.15585/mmwr.mm6909e1Google ScholarCrossref
    26.
    Chaw  L, Koh  WC, Jamaludin  SA, Naing  L, Alikhan  MF, Wong  J.  SARS-CoV-2 transmission in different settings: analysis of cases and close contacts from the Tablighi cluster in Brunei Darussalam.   Emerg Infect Dis. 2020;26(11):2598-2606. doi:10.3201/eid2611.202263Google ScholarCrossref
    27.
    Chen  Y, Wang  AH, Yi  B,  et al.  [Epidemiological characteristics of infection in COVID-19 close contacts in Ningbo city].   Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(5):667-671. doi:10.3760/cma.j.cn112338-20200304-00251PubMedGoogle Scholar
    28.
    Cheng  HY, Jian  SW, Liu  DP, Ng  TC, Huang  WT, Lin  HH; Taiwan COVID-19 Outbreak Investigation Team.  Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset.   JAMA Intern Med. 2020;180(9):1156-1163. doi:10.1001/jamainternmed.2020.2020PubMedGoogle ScholarCrossref
    29.
    Dattner  I, Goldberg  Y, Katriel  G,  et al.  The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children.   medRxiv. Preprint published online October 11, 2020. doi:10.1101/2020.06.03.20121145Google Scholar
    30.
    Dawson  P, Rabold  EM, Laws  RL,  et al.  Loss of taste and smell as distinguishing symptoms of COVID-19.   Clin Infect Dis. 2020;ciaa799. doi:10.1093/cid/ciaa799PubMedGoogle Scholar
    31.
    Dong  XC, Li  JM, Bai  JY,  et al.  [Epidemiological characteristics of confirmed COVID-19 cases in Tianjin].   Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(5):638-641. doi:10.3760/cma.j.cn112338-20200221-00146PubMedGoogle Scholar
    32.
    Doung-ngern  P, Suphanchaimat  R, Panjagampatthana  A,  et al.  Case-control study of use of personal protective measures and risk for SARS-CoV 2 infection, Thailand.   Emerg Infect Dis. 2020;26(11):2607-2616. doi:10.3201/eid2611.203003PubMedGoogle ScholarCrossref
    33.
    Draper  AD, Dempsey  KE, Boyd  RH,  et al.  The first 2 months of COVID-19 contact tracing in the Northern Territory of Australia, March-April 2020.   Commun Dis Intell (2018). 2020;44:44.PubMedGoogle Scholar
    34.
    Fateh-Moghadam  P, Battisti  L, Molinaro  S,  et al.  Contact tracing during phase I of the COVID-19 pandemic in the Province of Trento, Italy: key findings and recommendations.   medRxiv. Preprint published online July 29, 2020. doi:10.1101/2020.07.16.20127357Google Scholar
    35.
    Han  T.  Outbreak investigation: transmission of COVID-19 started from a spa facility in a local community in Korea.   Epidemiol Health. 2020;42(0):e2020056-e2020050. doi:10.4178/epih.e2020056PubMedGoogle ScholarCrossref
    36.
    Hu  S, Wang  W, Wang  Y,  et al.  Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China.   medRxiv. Preprint published online November 3, 2020. doi:10.1101/2020.07.23.20160317Google Scholar
    37.
    Hua  CZ, Miao  ZP, Zheng  JS,  et al.  Epidemiological features and viral shedding in children with SARS-CoV-2 infection.   J Med Virol. Published online June 15, 2020. doi:10.1002/jmv.26180PubMedGoogle Scholar
    38.
    Islam  SS, Noman  ASM. Transmission dynamics and contact tracing assessment of COVID-19 in Chattogram, Bangladesh and potential risk of close contacts at different exposure settings. Published October 12, 2020. Accessed November 11, 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3677863
    39.
    Jing  Q-L, Liu  M-J, Zhang  ZB,  et al.  Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.   Lancet Infect Dis. 2020;20(10):1141-1150. doi:10.1016/S1473-3099(20)30471-0PubMedGoogle ScholarCrossref
    40.
    Kim  J, Choe  YJ, Lee  J,  et al.  Role of children in household transmission of COVID-19.   Arch Dis Child. 2020;archdischild-2020-319910. doi:10.1136/archdischild-2020-319910PubMedGoogle Scholar
    41.
    COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention.  Coronavirus disease-19: summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea.   Osong Public Health Res Perspect. 2020;11(2):81-84. doi:10.24171/j.phrp.2020.11.2.04PubMedGoogle ScholarCrossref
    42.
    Laxminarayan  R, Wahl  B, Dudala  SR,  et al.  Epidemiology and transmission dynamics of COVID-19 in two Indian states.   Science. 2020;370(6517):691-697. doi:10.1126/science.abd7672PubMedGoogle ScholarCrossref
    43.
    Lee  M, Eun  Y, Park  K, Heo  J, Son  H.  Follow-up investigation of asymptomatic COVID-19 cases at diagnosis in Busan, Korea.   Epidemiol Health. 2020;42:e2020046. doi:10.4178/epih.e2020046PubMedGoogle Scholar
    44.
    Lewis  NM, Chu  VT, Ye  D,  et al.  Household transmission of SARS-CoV-2 in the United States.   Clin Infect Dis. Published online August 16, 2020. doi:10.1093/cid/ciaa1166Google Scholar
    45.
    Li  W, Zhang  B, Lu  J,  et al.  Characteristics of household transmission of COVID-19.   Clin Infect Dis. 2020;71(8):1943-1946. doi:10.1093/cid/ciaa450PubMedGoogle ScholarCrossref
    46.
    Liu  T, Liang  W, Zhong  H,  et al.  Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing.   Emerg Microbes Infect. 2020;9(1):1546-1553. doi:10.1080/22221751.2020.1787799PubMedGoogle ScholarCrossref
    47.
    Lopez Bernal  J, Panagiotopoulos  N, Byers  C,  et al.  Transmission dynamics of COVID-19 in household and community settings in the United Kingdom.   medRxiv. Preprint published online August 22, 2020. doi:10.1101/2020.08.19.20177188Google Scholar
    48.
    Luo  L, Liu  D, Liao  X,  et al.  Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study.   Ann Intern Med. Published August 13, 2020. doi:10.7326/M20-2671PubMedGoogle Scholar
    49.
    Lyngse  FP, Kirkeby  CT, Halasa  T,  et al.  COVID-19 transmission within Danish households: a nationwide study from lockdown to reopening.   medRxiv. Preprint published online September 9, 2020. doi:10.1101/2020.09.09.20191239Google Scholar
    50.
    Malheiro  R, Figueiredo  AL, Magalhães  JP,  et al.  Effectiveness of contact tracing and quarantine on reducing COVID-19 transmission: a retrospective cohort study.   Public Health. 2020;189:54-59. doi:10.1016/j.puhe.2020.09.012PubMedGoogle ScholarCrossref
    51.
    Park  YJ, Choe  YJ, Park  O,  et al; COVID-19 National Emergency Response Center, Epidemiology and Case Management Team.  Contact tracing during coronavirus disease outbreak, South Korea, 2020.   Emerg Infect Dis. 2020;26(10):2465-2468. doi:10.3201/eid2610.201315PubMedGoogle ScholarCrossref
    52.
    Park  SY, Kim  Y-M, Yi  S,  et al.  Coronavirus disease outbreak in call center, South Korea.   Emerg Infect Dis. 2020;26(8):1666-1670. doi:10.3201/eid2608.201274PubMedGoogle ScholarCrossref
    53.
    Patel  A, Charani  E, Ariyanayagam  D,  et al.  New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.   Clin Microbiol Infect. Published online June 2 2020.PubMedGoogle Scholar
    54.
    Phiriyasart  F, Chantutanon  S, Salaeh  F,  et al. Outbreak investigation of coronavirus disease (COVID-19) among Islamic missionaries in southern Thailand, April 2020. Outbreak, Surveillance, Investigation, and Response (OSIR) Journal. 2020;13(2). Accessed November 11, 2020. http://www.osirjournal.net/index.php/osir/article/view/195
    55.
    Rosenberg  ES, Dufort  EM, Blog  DS,  et al; New York State Coronavirus 2019 Response Team.  COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York State—March 2020.   Clin Infect Dis. 2020;71(8):1953-1959. doi:10.1093/cid/ciaa549PubMedGoogle ScholarCrossref
    56.
    Shah  K, Desai  N, Saxena  D, Mavalankar  D, Mishra  U, Patel  GC.  Household secondary attack rate in Gandhinagar district of Gujarat state from Western India.   medRxiv. Preprint published online September 5, 2020. doi:10.1101/2020.09.03.20187336Google Scholar
    57.
    Son  H, Lee  H, Lee  M,  et al.  Epidemiological characteristics of and containment measures for COVID-19 in Busan, South Korea.   Epidemiology and Health. 2020;42:e2020035. doi:10.4178/epih.e2020035PubMedGoogle Scholar
    58.
    Sun  WW, Ling  F, Pan  JR,  et al.  [Epidemiological characteristics of COVID-19 family clustering in Zhejiang Province].   Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(6):625-629. doi:10.3760/cma.j.cn112150-20200227-00199PubMedGoogle Scholar
    59.
    Teherani  MF, Kao  CM, Camacho-Gonzalez  A,  et al.  Burden of illness in households with SARS-CoV-2 infected children.   J Pediatric Infect Dis Soc. 2020;9(5):613-616. doi:10.1093/jpids/piaa097PubMedGoogle ScholarCrossref
    60.
    van der Hoek  W, Backer  JA, Bodewes  R,  et al.  [The role of children in the transmission of SARS-CoV-2].   Ned Tijdschr Geneeskd. 2020;164:D5140.PubMedGoogle Scholar
    61.
    Wang  Z, Ma  W, Zheng  X, Wu  G, Zhang  R.  Household transmission of SARS-CoV-2.   J Infect. 2020;81(1):179-182. doi:10.1016/j.jinf.2020.03.040PubMedGoogle ScholarCrossref
    62.
    Wang  X, Pan  Y, Zhang  D,  et al.  Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China.   BMC Infect Dis. 2020;20(1):526. doi:10.1186/s12879-020-05251-9PubMedGoogle ScholarCrossref
    63.
    Wang  Y, Tian  H, Zhang  L,  et al.  Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China.   BMJ Glob Health. 2020;5(5):e002794. doi:10.1136/bmjgh-2020-002794PubMedGoogle Scholar
    64.
    Wang  X, Zhou  Q, He  Y,  et al.  Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China.   Eur Respir J. 2020;55(6):2000544. doi:10.1183/13993003.00544-2020PubMedGoogle Scholar
    65.
    Wu  J, Huang  Y, Tu  C,  et al.  Household transmission of SARS-CoV-2, Zhuhai, China, 2020.   Clin Infect Dis. Published online May 11, 2020;ciaa557. doi:10.1093/cid/ciaa557PubMedGoogle Scholar
    66.
    Wu  Y, Song  S, Kao  Q, Kong  Q, Sun  Z, Wang  B.  Risk of SARS-CoV-2 infection among contacts of individuals with COVID-19 in Hangzhou, China.   Public Health. 2020;185:57-59. doi:10.1016/j.puhe.2020.05.016PubMedGoogle ScholarCrossref
    67.
    Xin  H, Jiang  F, Xue  A,  et al.  Risk factors associated with occurrence of COVID-19 among household persons exposed to patients with confirmed COVID-19 in Qingdao Municipal, China.   Transbound Emerg Dis. 2020. doi:10.1111/tbed.13743PubMedGoogle Scholar
    68.
    Yu  HJ, Hu  YF, Liu  XX,  et al.  Household infection: the predominant risk factor for close contacts of patients with COVID-19.   Travel Med Infect Dis. 2020;36:101809. doi:10.1016/j.tmaid.2020.101809PubMedGoogle Scholar
    69.
    Yung  CF, Kam  KQ, Chong  CY,  et al.  Household transmission of SARS-CoV-2 from adults to children.   J Ped. 2020;225:249-251. doi:10.1016/j.jpeds.2020.07.009Google ScholarCrossref
    70.
    Zhang  W, Cheng  W, Luo  L,  et al.  Secondary transmission of coronavirus disease from presymptomatic persons, China.   Emerg Infect Dis. 2020;26(8):1924-1926. doi:10.3201/eid2608.201142PubMedGoogle ScholarCrossref
    71.
    Zhang  JZ, Zhou  P, Han  DB,  et al.  [Investigation on a cluster epidemic of COVID-19 in a supermarket in Liaocheng, Shandong province].   Zhonghua Liu Xing Bing Xue Za Zhi. Published April 27, 2020.PubMedGoogle Scholar
    72.
    Zhuang  YL, Zhang  YT, Li  M,  et al.  [Analysis on the cluster epidemic of coronavirus disease 2019 in Guangdong Province].   Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(7):720-725.PubMedGoogle Scholar
    73.
    Stringhini  S, Wisniak  A, Piumatti  G,  et al.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.   Lancet. 2020;396(10247):313-319. doi:10.1016/S0140-6736(20)31304-0PubMedGoogle ScholarCrossref
    74.
    Yang  K, Wang  L, Li  F,  et al.  Analysis of epidemiological characteristics of coronavirus 2019 infection and preventive measures in Shenzhen China: a heavy population city.   medRxiv. Preprint published online March 3, 2020. doi:10.1101/2020.02.28.20028555Google Scholar
    75.
    Fontanet  A, Grant  R, Tondeur  L,  et al.  SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission.   medRxiv. Preprint published online June 29, 2020. doi:10.1101/2020.06.25.20140178Google Scholar
    76.
    Chan  LY, Wong  JT, Li  PK, Lui  SF, Fung  H, Sung  J.  Risk of transmission of severe acute respiratory syndrome to household contacts by infected health care workers and patients.   Am J Med. 2004;116(8):559-560. doi:10.1016/j.amjmed.2003.11.011PubMedGoogle ScholarCrossref
    77.
    Goh  DL, Lee  BW, Chia  KS,  et al.  Secondary household transmission of SARS, Singapore.   Emerg Infect Dis. 2004;10(2):232-234. doi:10.3201/eid1002.030676PubMedGoogle ScholarCrossref
    78.
    Lau  JT, Lau  M, Kim  JH, Tsui  HY, Tsang  T, Wong  TW.  Probable secondary infections in households of SARS patients in Hong Kong.   Emerg Infect Dis. 2004;10(2):235-243. doi:10.3201/eid1002.030626PubMedGoogle Scholar
    79.
    Wilson-Clark  SD, Deeks  SL, Gournis  E,  et al.  Household transmission of SARS, 2003.   CMAJ. 2006;175(10):1219-1223. doi:10.1503/cmaj.050876PubMedGoogle ScholarCrossref
    80.
    Ou  J, Li  Q, Zeng  G, Dun  Z; Centers for Disease Control and Prevention (CDC).  Efficiency of quarantine during an epidemic of severe acute respiratory syndrome—Beijing, China, 2003.   MMWR Morb Mortal Wkly Rep. 2003;52(43):1037-1040.PubMedGoogle Scholar
    81.
    Tuan  PA, Horby  P, Dinh  PN,  et al; WHO SARS Investigation Team in Vietnam.  SARS transmission in Vietnam outside of the health-care setting.   Epidemiol Infect. 2007;135(3):392-401. doi:10.1017/S0950268806006996PubMedGoogle ScholarCrossref
    82.
    Pang  X, Zhu  Z, Xu  F,  et al.  Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003.   JAMA. 2003;290(24):3215-3221. doi:10.1001/jama.290.24.3215PubMedGoogle ScholarCrossref
    83.
    Al Hosani  FI, Kim  L, Khudhair  A,  et al.  Serologic follow-up of Middle East respiratory syndrome coronavirus cases and contacts—Abu Dhabi, United Arab Emirates.   Clin Infect Dis. 2019;68(3):409-418. doi:10.1093/cid/ciy503PubMedGoogle ScholarCrossref
    84.
    Arwady  MA, Alraddadi  B, Basler  C,  et al.  Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014.   Emerg Infect Dis. 2016;22(8):1395-1402. doi:10.3201/eid2208.152015PubMedGoogle ScholarCrossref
    85.
    Assiri  A, McGeer  A, Perl  TM,  et al; KSA MERS-CoV Investigation Team.  Hospital outbreak of Middle East respiratory syndrome coronavirus.   N Engl J Med. 2013;369(5):407-416. doi:10.1056/NEJMoa1306742PubMedGoogle ScholarCrossref
    86.
    Drosten  C, Meyer  B, Müller  MA,  et al.  Transmission of MERS-coronavirus in household contacts.   N Engl J Med. 2014;371(9):828-835. doi:10.1056/NEJMoa1405858PubMedGoogle ScholarCrossref
    87.
    Memish  ZA, Al-Tawfiq  JA, Alhakeem  RF,  et al.  Middle East respiratory syndrome coronavirus (MERS-CoV): a cluster analysis with implications for global management of suspected cases.   Travel Med Infect Dis. 2015;13(4):311-314. doi:10.1016/j.tmaid.2015.06.012PubMedGoogle ScholarCrossref
    88.
    Payne  DC, Biggs  HM, Al-Abdallat  MM,  et al.  Multihospital outbreak of a Middle East respiratory syndrome coronavirus deletion variant, Jordan: a molecular, serologic, and epidemiologic investigation.   Open Forum Infect Dis. 2018;5(5):ofy095. doi:10.1093/ofid/ofy095PubMedGoogle Scholar
    89.
    Van Kerkhove  MD, Alaswad  S, Assiri  A,  et al.  Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015.   Emerg Infect Dis. 2019;25(10):1802-1809. doi:10.3201/eid2510.190130PubMedGoogle ScholarCrossref
    90.
    Esposito  S, Bosis  S, Niesters  HG,  et al.  Impact of human coronavirus infections in otherwise healthy children who attended an emergency department.   J Med Virol. 2006;78(12):1609-1615. doi:10.1002/jmv.20745PubMedGoogle ScholarCrossref
    91.
    Monto  AS, DeJonge  PM, Callear  AP,  et al.  Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan.   J Infect Dis. 2020;222(1):9-16. doi:10.1093/infdis/jiaa161PubMedGoogle ScholarCrossref
    92.
    Beale  S, Lewer  D, Aldridge  RW,  et al.  Household transmission of seasonal coronavirus infections: results from the Flu Watch cohort study.   Wellcome Open Research. 2020;5(145):145. doi:10.12688/wellcomeopenres.16055.1Google ScholarCrossref
    93.
    Tsang  TK, Lau  LLH, Cauchemez  S, Cowling  BJ.  Household transmission of influenza virus.   Trends Microbiol. 2016;24(2):123-133. doi:10.1016/j.tim.2015.10.012PubMedGoogle ScholarCrossref
    94.
    Ministry of Health, Labour, and Welfare. Avoid the “Three Cs”! Accessed August 5, 2020. https://www.mhlw.go.jp/content/10900000/000619576.pdf
    95.
    Pang  X, Yang  P, Li  S,  et al.  Pandemic (H1N1) 2009 among quarantined close contacts, Beijing, People’s Republic of China.   Emerg Infect Dis. 2011;17(10):1824-1830. doi:10.3201/eid1710.101344PubMedGoogle ScholarCrossref
    96.
    Tam  K, Yousey-Hindes  K, Hadler  JL.  Influenza-related hospitalization of adults associated with low census tract socioeconomic status and female sex in New Haven County, Connecticut, 2007-2011.   Influenza Other Respir Viruses. 2014;8(3):274-281. doi:10.1111/irv.12231PubMedGoogle ScholarCrossref
    97.
    Chandrasekhar  R, Sloan  C, Mitchel  E,  et al.  Social determinants of influenza hospitalization in the United States.   Influenza Other Respir Viruses. 2017;11(6):479-488. doi:10.1111/irv.12483PubMedGoogle ScholarCrossref
    98.
    Sloan  C, Chandrasekhar  R, Mitchel  E, Schaffner  W, Lindegren  ML.  Socioeconomic disparities and influenza hospitalizations, Tennessee, USA.   Emerg Infect Dis. 2015;21(9):1602-1610. doi:10.3201/eid2109.141861PubMedGoogle ScholarCrossref
    99.
    Viner  RM, Mytton  OT, Bonell  C,  et al.  Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis.   JAMA Pediatr. Published September 25, 2020. doi:10.1001/jamapediatrics.2020.4573PubMedGoogle Scholar
    100.
    Davies  NG, Klepac  P, Liu  Y, Prem  K, Jit  M, Eggo  RM; CMMID COVID-19 working group.  Age-dependent effects in the transmission and control of COVID-19 epidemics.   Nat Med. 2020;26(8):1205-1211. doi:10.1038/s41591-020-0962-9PubMedGoogle ScholarCrossref
    101.
    Huang  AT, Garcia-Carreras  B, Hitchings  MDT,  et al.  A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.   Nat Commun. 2020;11(1):4704. doi:10.1038/s41467-020-18450-4PubMedGoogle ScholarCrossref
    102.
    Mehta  NS, Mytton  OT, Mullins  EWS,  et al.  SARS-CoV-2 (COVID-19): what do we know about children? a systematic review.   Clin Infect Dis. Published May 11, 2020;ciaa556. doi:10.1093/cid/ciaa556PubMedGoogle Scholar
    103.
    Posfay-Barbe  KM, Wagner  N, Gauthey  M,  et al.  COVID-19 in children and the dynamics of infection in families.   Pediatrics. 2020;146(2):e20201576. doi:10.1542/peds.2020-1576PubMedGoogle Scholar
    104.
    Lee  B, Raszka  WV  Jr.  COVID-19 transmission and children: the child is not to blame.   Pediatrics. 2020;146(2):e2020004879. doi:10.1542/peds.2020-004879PubMedGoogle Scholar
    105.
    Zhu  Y, Bloxham  CJ, Hulme  KD,  et al.  Children are unlikely to have been the primary source of household SARS-CoV-2 infections.   medRxiv. Preprint published online March 30, 2020. doi:10.1101/2020.03.26.20044826Google Scholar
    106.
    L'Huillier  AG, Torriani  G, Pigny  F, Kaiser  L, Eckerle  I.  Culture-competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents.   Emerg Infect Dis. 2020;26(10):2494-2497. doi:10.3201/eid2610.202403Google ScholarCrossref
    107.
    World Health Organization. Gender and COVID-19. Published May 14, 2020. Accessed November 11, 2020. https://www.who.int/publications/i/item/gender-and-covid-19
    108.
    Walsh  KA, Jordan  K, Clyne  B,  et al.  SARS-CoV-2 detection, viral load and infectivity over the course of an infection.   J Infect. 2020;81(3):357-371. doi:10.1016/j.jinf.2020.06.067PubMedGoogle ScholarCrossref
    109.
    He  X, Lau  EHY, Wu  P,  et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19.   Nat Med. 2020;26(5):672-675. doi:10.1038/s41591-020-0869-5PubMedGoogle ScholarCrossref
    110.
    Ali  ST, Wang  L, Lau  EHY,  et al.  Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions.   Science. 2020;369(6507):1106-1109. doi:10.1126/science.abc9004PubMedGoogle ScholarCrossref
    111.
    Rabaan  AA, Al-Ahmed  SH, Haque  S,  et al.  SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview.   Infez Med. 2020;28(2):174-184.PubMedGoogle Scholar
    112.
    Petersen  E, Koopmans  M, Go  U,  et al.  Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.   Lancet Infect Dis. 2020;20(9):e238-e244. doi:10.1016/S1473-3099(20)30484-9PubMedGoogle ScholarCrossref
    113.
    Petrosillo  N, Viceconte  G, Ergonul  O, Ippolito  G, Petersen  E.  COVID-19, SARS and MERS: are they closely related?   Clin Microbiol Infect. 2020;26(6):729-734. doi:10.1016/j.cmi.2020.03.026PubMedGoogle ScholarCrossref
    114.
    Fraser  C, Riley  S, Anderson  RM, Ferguson  NM.  Factors that make an infectious disease outbreak controllable.   Proc Natl Acad Sci U S A. 2004;101(16):6146-6151. doi:10.1073/pnas.0307506101PubMedGoogle ScholarCrossref
    115.
    Cowling  BJ, Park  M, Fang  VJ, Wu  P, Leung  GM, Wu  JT.  Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015.   Euro Surveill. 2015;20(25):7-13. doi:10.2807/1560-7917.ES2015.20.25.21163PubMedGoogle ScholarCrossref
    ×